Literature DB >> 8031925

The national STD surveillance system in Italy: results of the first year of activity. STD Surveillance Working Group.

B Suligoi1, M Giuliani, N Binkin.   

Abstract

A prospective STD surveillance system was developed in Italy in 1990. Newly diagnosed cases of sexually transmitted disease (STD) are reported by a network of 45 sentinel STD clinics throughout the country. A total of 10,253 patients were reported between September 1990 and December 1991. The most frequent diagnoses were genital warts (30.8%), non-specific genital infection (male) (12.8%), and non-specific genital infection (female) (11.5%). All patients were asked to undergo an HIV test; 68.4% accepted, of whom 9.3% were seropositive. During the 16-month study period HIV prevalence decreased among IDUs and homo-bisexuals, but increased among non-IDU heterosexuals. These data suggest that STD patients may represent a useful early warning system to detect changes in the epidemic and in the spread of the virus among low-risk heterosexuals. A better counselling programme is needed to improve the acceptance rate of HIV testing among STD patients, and to draw more attention to at-risk sexual behaviours.

Entities:  

Mesh:

Year:  1994        PMID: 8031925     DOI: 10.1177/095646249400500203

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  3 in total

Review 1.  The role of epidemiology and surveillance systems in the control of sexually transmitted diseases.

Authors:  M A Catchpole
Journal:  Genitourin Med       Date:  1996-10

2.  Low seroprevalence of HTLV-I and HTLV-II in patients with a sexually transmitted disease. Study Group for HTLV and STDs.

Authors:  B Suligoi; C Galli; S Ciuta; R Decker
Journal:  Eur J Epidemiol       Date:  1999-03       Impact factor: 8.082

3.  Trends in gonorrhoea in nine western European countries, 1991-6. European Study Group.

Authors:  J H Van der Heyden; M A Catchpole; W J Paget; A Stroobant
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.